The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Knowing what to include in your retirement portfolio at 30 can set you up for success. Learn about essential assets and strategies.
20,618 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A choppy week toppled many growth names, but poet technologies stock sliding captured particular attention. Here’s wh...
Britain’s bond panic currently reshapes how households view cash, debt, and even crypto, as gilt volatility and infla...
A high-quality stock has endured a 19% drop over seven months. This article breaks down how to tell whether the decli...
A letter allegedly from Sam Bankman-Fried is under intense scrutiny as prosecutors question its authenticity. Amid fa...
A solid one-day move in Venture Global stock rose today as analysts lifted price targets and LNG demand expectations ...
As crypto markets shift, only these crypto tokens sit closest to their all-time highs, signaling selective strength e...
A former hedge-fund executive warns that investors dangerously complacent about Iran conflict risks as oil volatility...
Microsoft stock slid about 25% in Q1 2026, its worst showing in years, as AI spending accelerates yet revenue signals...
NVIDIA’s shares hover near $198 as investors weigh whether the AI leader’s growth justifies a premium. The stock now ...
Biote's Q1 2026 earnings call reveals critical insights into revenue growth, margins, and a promising pipeline. This ...
The U.K. edition of Saturday Night Live is renewed for a second season, underscoring a new model where social-clip vi...